- Roche (OTCQX:RHHBY) plans to continue its strategy of focusing on smaller acquisitions and partnerships rather than the big M&A deals that have been spreading across the healthcare industry.
- "We're sticking to our previous strategy. This includes targeted, small acquisitions and partnerships like the ones we have carried out in recent months," says CEO Severin Schwan. "We have to weigh up internal and external opportunities. It can't be that we have to put important internal opportunities on ice because of too-expensive acquisitions."
- The company has acquired a few small diagnostic companies this year including the recent purchase of Seragon Pharmaceuticals and Genia Technologies.
at Zacks.com (Tue, 6:26PM)